Latest Research in Pharmaceutical Practices and Patient Outcomes

17 research papers · 2026 median publication year

Top Research Topics in Pharmaceutical Practices and Patient Outcomes

Highest-Cited Papers

  1. Levofloxacin-based concomitant versus sequential therapy for Helicobacter pylori eradication in treatment-naïve Syrian patients: a randomized trial showing no superiority of sequential therapy
  2. Fourteen-Day Amoxicillin- or Tetracycline-Containing Bismuth Quadruple Therapy versus 14-Day Metronidazole-Based Triple Therapy as the Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial
  3. Reconsidering First-Line Therapy for Clarithromycin-Resistant Helicobacter pylori in Korea: The Role of Bismuth-Augmented Triple Therapy
  4. Potassium-competitive acid blocker versus proton pump inhibitor as a part of bismuth-based quadruple therapy for treatment of Helicobacter pylori infection: a randomized controlled trial
  5. Efficacy and safety of probiotics combined with P-CAB-containing dual therapy for Helicobacter pylori eradication: a meta-analysis
  6. Randomized controlled trial comparing 7-day fexuprazan-based and 14-day rabeprazole-based triple therapies for Helicobacter pylori eradication
  7. Beyond Dual Therapy: Rethinking Tegoprazan–Amoxicillin for H. pylori
  8. Evaluation of Posttreatment Eradication Testing Following Helicobacter pylori Therapy
  9. ASSESSING THE HISTOPATHOLOGICAL CORRELATES AND PREVALENCE OF H PYLORI IN GASTRITIS CASES PROVED ON BIOPSY
  10. The efficacy and safety of Helicobacter pylori eradication regimens in patients receiving hemodialysis: a systematic review and network meta-analysis.
  11. Methodological Considerations Regarding the Meta‐Analysis of Tegoprazan–Amoxicillin Dual Therapy for Helicobacter pylori Eradication
  12. Comparable tolerability, symptom worsening, and treatment completion rates among different Helicobacter pylori eradication regimens in children
  13. Comparative effects of vonoprazan-based and esomeprazole-based dual therapy on Helicobacter pylori eradication and short-term gut microbiota changes
  14. Comprehensive Pharmaceutical Care and Service-Related Outcomes During Vonoprazan-Amoxicillin Dual Therapy in Elderly Patients: A Retrospective Cohort Study
  15. Peptic Ulcer Disease in Pediatrics: A Comprehensive Review
  16. Efficacy of Fexuprazan-based Concomitant Therapy for Helicobacter pylori Infection.
  17. Optimization of Minocycline‐Containing Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Randomized Controlled Trial
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
L3 Region - - 2026 Sep Q3

Pharmaceutical Practices and Patient Outcomes

17 papers

Top Topics (2)

Helicobacter pylori-related gastroenterology studies16
Pharmaceutical Practices and Patient Outcomes1

Top Publications (17)

1.Levofloxacin-based concomitant versus sequential therapy for Helicobacter pylori eradication in treatment-naïve Syrian patients: a randomized trial showing no superiority of sequential therapy2.Fourteen-Day Amoxicillin- or Tetracycline-Containing Bismuth Quadruple Therapy versus 14-Day Metronidazole-Based Triple Therapy as the Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial3.Reconsidering First-Line Therapy for Clarithromycin-Resistant Helicobacter pylori in Korea: The Role of Bismuth-Augmented Triple Therapy4.Potassium-competitive acid blocker versus proton pump inhibitor as a part of bismuth-based quadruple therapy for treatment of Helicobacter pylori infection: a randomized controlled trial5.Efficacy and safety of probiotics combined with P-CAB-containing dual therapy for Helicobacter pylori eradication: a meta-analysis6.Randomized controlled trial comparing 7-day fexuprazan-based and 14-day rabeprazole-based triple therapies for Helicobacter pylori eradication7.Beyond Dual Therapy: Rethinking Tegoprazan–Amoxicillin for H. pylori8.Evaluation of Posttreatment Eradication Testing Following Helicobacter pylori Therapy9.ASSESSING THE HISTOPATHOLOGICAL CORRELATES AND PREVALENCE OF H PYLORI IN GASTRITIS CASES PROVED ON BIOPSY10.The efficacy and safety of Helicobacter pylori eradication regimens in patients receiving hemodialysis: a systematic review and network meta-analysis.11.Methodological Considerations Regarding the Meta‐Analysis of Tegoprazan–Amoxicillin Dual Therapy for Helicobacter pylori Eradication12.Comparable tolerability, symptom worsening, and treatment completion rates among different Helicobacter pylori eradication regimens in children13.Comparative effects of vonoprazan-based and esomeprazole-based dual therapy on Helicobacter pylori eradication and short-term gut microbiota changes14.Comprehensive Pharmaceutical Care and Service-Related Outcomes During Vonoprazan-Amoxicillin Dual Therapy in Elderly Patients: A Retrospective Cohort Study15.Peptic Ulcer Disease in Pediatrics: A Comprehensive Review16.Efficacy of Fexuprazan-based Concomitant Therapy for Helicobacter pylori Infection.17.Optimization of Minocycline‐Containing Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Randomized Controlled Trial
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.